Pyxis Oncology, Inc. (PYXS) Investor Relations Documents

Pyxis Oncology, Inc. (PYXS) investor relations documents from the company's IR site: 2 presentations, 38 press releases; latest deck 2026-08-12. Read in-app with summaries. First-party data.

August 2026 Corporate Deck: This document details PYXS's ADC candidate, MICVO, targeting EDB+FN for R/M HNSCC, with promising Phase 1 data and multiple catalysts expected in 2H 2026.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-13Press releasePyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
2026-08-12PresentationAugust 2026 Corporate Deck
2026-06-30Press releasePyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones
2026-05-14Press releasePyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
2026-05-13Press releasePyxis Oncology to Participate in Upcoming Investor Conferences
2026-05-07Press releasePyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
2026-04-17Press releasePyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in
2026-03-23Press releasePyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-03Press releasePyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Contin
2025-12-18Press releasePyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Hea
2025-12-17PresentationPyxis Oncology MICVO R/M HNSCC Clinical Update Presentation
2025-11-03Press releasePyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
2025-11-03Press releasePyxis Oncology to Participate in Upcoming Investor Conferences
2025-08-21Press releasePDF Version
Press releasePyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Press releasePyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
2025-05-14Press releasePDF Version
2025-04-25Press releasePDF Version
2025-04-02Press releasePDF Version
2025-03-25Press releasePDF Version
2025-03-18Press releasePDF Version
2025-03-18Press releasePyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
2025-03-03Press releasePDF Version
2025-02-26Press releasePDF Version
2025-02-04Press releasePDF Version
2024-11-20Press releasePDF Version
2024-11-12Press releasePyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
2024-11-11Press releasePDF Version
2024-11-11Press releasePyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminar
2024-08-29Press releasePDF Version
2024-08-14Press releasePyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
2024-07-29Press releasePDF Version
2024-05-30Press releasePDF Version
2024-05-14Press releasePDF Version
2024-05-14Press releasePyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
2024-03-21Press releasePDF Version
2024-03-21Press releasePyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
2024-03-07Press releasePDF Version
2024-03-05Press releasePDF Version
2023-11-07Press releasePDF Version

PYXS overview · PYXS earnings · PYXS financials · PYXS KPIs · PYXS ownership · PYXS peers · PYXS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.